Literature DB >> 12656448

An update on 'progression promoters' in renal diseases.

C O Alebiosu1.   

Abstract

AIM: This paper reviews progression in renal diseases.
METHODS: An English language literature search using Medline (1980 January-2001 July) was done to assess research and review articles on progression in renal diseases.
RESULTS: Factors that increase the risk of progression in renal diseases are hypertension, dyslipidaemia, underlying nephropathy, high dietary protein intake and proteinuria. Others are smoking, hyperglycemia, low birth weight, obesity, metabolic syndrome X, genetic factors such as angiotensin converting enzyme 'DD' genotype and chromosome 1q21, and exposure to lead. Hypertension induces arteriolar nephrosclerosis. The mechanisms whereby lipids contribute to vascular and renal injury are incompletely understood. Glomerular hyperperfusion and increased proteinuria may explain the adverse effects of increased protein intake on renal disease progression. Proteinuria contains numerous toxic/inflammatory systems that promote progression. Cigarette smoking has vasoconstrictive, thrombotic and direct toxic effects on the vascular epithelium. Hyperglycemia is strongly implicated in the progression of complications in diabetics. Oligonephropathy in low birth weight has been suggested to increase the risk for systemic and glomerular hypertension in adult life. In obesity, the combination of hyperfiltration, glomerular hypertrophy and glomerular hypertension is a primary initiating event for glomerular injury manifesting as glomerulomegally and focal and segmental glomerulosclerosis and proteinuria. Angiotensin I, with enzyme insertion/deletion polymorphism, especially the "DD" genotype, predisposes to a rapid decline in renal function. Finally, long-term exposure to low levels of environmental lead affects renal function.
CONCLUSION: The control of hypertension, dyslipidaemia, proteinuria, obesity, avoidance of low birth weight, smoking and heavy metals such as lead are intervention strategies for preventing progression of renal diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12656448      PMCID: PMC2594375     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  78 in total

1.  Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy.

Authors:  M Touam; J Zingraff; P Jungers; B Chadefaux-Vekemans; T Drüeke; Z A Massy
Journal:  Kidney Int       Date:  1999-12       Impact factor: 10.612

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 3.  Aldose reductase and the role of the polyol pathway in diabetic nephropathy.

Authors:  M Dunlop
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

4.  Overweight and obesity in the United States: prevalence and trends, 1960-1994.

Authors:  K M Flegal; M D Carroll; R J Kuczmarski; C L Johnson
Journal:  Int J Obes Relat Metab Disord       Date:  1998-01

Review 5.  The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

Authors:  R E Gilbert; M E Cooper
Journal:  Kidney Int       Date:  1999-11       Impact factor: 10.612

Review 6.  Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists.

Authors:  M W Taal; B M Brenner
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

7.  Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population.

Authors:  J M Halimi; B Giraudeau; S Vol; E Cacès; H Nivet; Y Lebranchu; J Tichet
Journal:  Kidney Int       Date:  2000-09       Impact factor: 10.612

8.  Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

Authors:  S E Inzucchi; D G Maggs; G R Spollett; S L Page; F S Rife; V Walton; G I Shulman
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

9.  Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats.

Authors:  Jaap A Joles; Uta Kunter; Ulf Janssen; Wilhelm Kriz; Ton J Rabelink; Hein A Koomans; Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2000-04       Impact factor: 10.121

Review 10.  Homocysteine and cardiovascular disease.

Authors:  H Refsum; P M Ueland; O Nygård; S E Vollset
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

View more
  6 in total

Review 1.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

2.  Chronic renal failure at the Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria.

Authors:  C Olutayo Alebiosu; Olugbenga O Ayodele; Adigun Abbas; A Ina Olutoyin
Journal:  Afr Health Sci       Date:  2006-09       Impact factor: 0.927

3.  Proteinuria in South Asian children: prevalence and determinants.

Authors:  Tazeen H Jafar; Nish Chaturvedi; Juanita Hatcher; Iqtidar Khan; Anas Rabbani; Abdul Qayum Khan; Ronald Portman; Christopher H Schmid; Andrew S Levey
Journal:  Pediatr Nephrol       Date:  2005-06-10       Impact factor: 3.714

4.  Metabolic syndrome in subjects with type-2 diabetes mellitus.

Authors:  Christopher Olutayo Alebiosu; B Olatunde Odusan
Journal:  J Natl Med Assoc       Date:  2004-06       Impact factor: 1.798

5.  Protective Effects of Combination of Radix Astragali and Radix Salviae Miltiorrhizae on Kidney of Spontaneously Hypertensive Rats and Renal Intrinsic Cells.

Authors:  Wei Li; Yue-Hua Jiang; Yan Wang; Meng Zhao; Guang-Jian Hou; Hong-Zhen Hu; Le Zhou
Journal:  Chin J Integr Med       Date:  2019-08-05       Impact factor: 1.978

6.  INSAF-HAS: a tool to select patients with hypertension for pharmaceutical care.

Authors:  Beatriz Maria Pereira Girolineto; Alan Maicon de Oliveira; Ana Maria Rosa Freato Gonçalves; Marília Silveira de Almeida Campos; Leonardo Régis Leira Pereira
Journal:  Einstein (Sao Paulo)       Date:  2019-12-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.